National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01AX03	TEGOZOL	G	Temozolomide - 100mg	100mg	Capsule	5,012,533 L.L
L01AX03	TEMODAL	B	Temozolomide - 20mg	20mg	Capsule	1,612,611 L.L
L01AX03	TEGOZOL	G	Temozolomide - 20mg	100mg	Capsule	1,022,664 L.L
L04AX07	TECFEO 240	G	Dimethyl Fumarate - 240mg	240mg	Capsule, delayed release	67,784,092 L.L
C10BX06	TRINOMIA	B	Acetylsalicylic acid - 100mg, Atorvastatin - 20mg, Ramipril - 2.5mg		Capsule, hard	1,029,383 L.L
C10BX06	TRINOMIA	B	Acetylsalicylic acid - 100mg, Atorvastatin - 20mg, Ramipril - 5mg		Capsule, hard	1,236,335 L.L
C10BX06	TRINOMIA	B	Acetylsalicylic acid - 100mg, Atorvastatin - 20mg, Ramipril - 10mg		Capsule, hard	1,596,485 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 250mg	250mg	Capsule, hard	13,397,927 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 250mg	250mg	Capsule, hard	12,058,004 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 100mg	100mg	Capsule, hard	5,590,385 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 100mg	100mg	Capsule, hard	4,511,279 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 20mg	20mg	Capsule, hard	1,153,017 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 20mg	20mg	Capsule, hard	920,532 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 5mg	5mg	Capsule, hard	1,153,017 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 5mg	5mg	Capsule, hard	1,153,017 L.L
G04CA02	TAMSU GENERICON RETARD	G	Tamsulosin - 0.4mg	0.4mg	Capsule, hard, modified release	615,480 L.L
G04CA02	TALUSIN	G	Tamsulosin HCl - 0.4mg	0.4mg	Capsule, modified release	683,440 L.L
C08DA51	TARKA	B	Verapamil - 180mg, Trandolapril - 2mg		Capsule, modified release	2,422,948 L.L
D01AE15	TERAFAN	G	Terbinafine HCl - 1%	1%	Cream	499,142 L.L
D07CC01	TOPIZONE	G	Fusidic acid - 20mg/g, Betamethasone (valerate) - 1mg/g		Cream	216,359 L.L
D07XC04	TRAVOCORT	B	Diflucortolone valerate - 0.1%, Isoconazole nitrate - 1%		Cream	435,405 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Drops	322,522 L.L
S01XA20	TEARS NATURALE	B	Duasorb - 0.4%	0.4%	Drops solution	189,482 L.L
S02AA30	TYOTOCIN	B	Hexylresorcinol - 0.1%, Antipyrine - 5%, Benzocaine - 1.25%, Tyrothricin - 0.05%		Drops solution	409,552 L.L
S01AA12	TOBRASTILL	G	Tobramycin - 0.3%	0.3%	Drops solution	258,018 L.L
S01AE06	TYMER	G	Gatifloxacin (sesquihydrate) - 3mg/ml	3mg/ml	Drops solution	427,342 L.L
N06BX06	TRAUSAN	G	Citicoline - 100mg/ml	100mg/ml	Drops solution	807,649 L.L
S01ED51	TWINZOL	G	Dorzolamide HCl - 2%, Timolol - 0.5%		Drops solution	632,950 L.L
S01ED51	TRAVOPROST/TIMOLOL BIOGARAN	G	Travoprost - 40mcg/ml, Timolol - 5mg/ml		Drops solution	849,308 L.L
S01EE04	TRAVATAN	B	Travoprost - 40mcg/ml	0.004%	Drops solution	806,306 L.L

National Cancer Registry (NCR)